Regulators traced a fake inhaler to one address.

Nigeria’s drug agency said the counterfeit Pulmicort copy could cause treatment failure during an asthma attack, discovered too late.

NAFDAC has ordered nationwide mop-up operations while it investigates the distribution network behind the batch.

Sources: Premium Times Nigeria